Article Details
Retrieved on: 2025-09-22 21:24:32
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
A trial of more than 3,000 healthy full-term infants shows clesrovimab, a single-dose monoclonal antibody, reduced the incidence of respiratory ...
Article found on: www.cidrap.umn.edu
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here